Regulatory T cells of clinically responding SSc patients had increased levels of the immune regulators cytotoxic T lymphocyte-associated protein 4 (CTLA-4), a negative regulator of T cell function, and glucocorticoid-induced TNFR-related protein compared with non-responders (28). Here, CTLA4 is linked to systemic sclerosis.